Ibuprofen
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Ibuprom RR MAX is a pain-relieving, anti-inflammatory, and antipyretic medicine. It is used to treat mild to moderate acute pain: post-operative, muscular, bone, migraine, and menstrual. The medicine is also used to reduce mild to moderate pain of various origins: headache, toothache, lower back pain, neuralgia, joint pain, and fever (in the course of a cold or flu).
Before starting treatment with Ibuprom RR MAX, the patient should discuss it with their doctor or pharmacist.
1/7
There is a risk of gastrointestinal bleeding, ulceration, or perforation, which can be fatal and does not necessarily have to be preceded by warning signs or may occur in patients who have had such warning signs. If gastrointestinal bleeding or ulceration occurs, the medicine should be discontinued immediately. Patients with a history of gastrointestinal diseases, especially the elderly, should inform their doctor about any unusual gastrointestinal symptoms (especially bleeding), especially during the initial treatment period.
Concomitant, long-term use of different painkillers may lead to kidney damage with a risk of kidney failure (analgesic nephropathy).
Care should be taken in dehydrated patients (youth) due to the increased risk of kidney function disorders.
Taking anti-inflammatory and pain-relieving medicines, such as ibuprofen, may be associated with a slight increase in the risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose and duration of treatment.
During treatment with ibuprofen, symptoms of allergic reactions to this medicine have occurred, including difficulty breathing, facial and neck swelling (angioedema), chest pain.
If any of these symptoms are noticed, the medicine Ibuprom RR MAX should be discontinued immediately and medical help should be sought.
Before taking Ibuprom RR MAX, the patient should discuss the treatment with their doctor or pharmacist if:
Do not take higher doses or longer treatment than recommended.
If symptoms persist, worsen, or do not improve after 3 days, or if new symptoms occur, consult a doctor.
2/7
In connection with the use of ibuprofen, severe skin reactions have occurred, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If the patient experiences any symptoms related to these severe skin reactions described in section 4, they should discontinue Ibuprom RR MAX and seek medical help.
Infections
Ibuprom RR MAX may mask the symptoms of an infection, such as fever and pain. Therefore, Ibuprom RR MAX may delay the use of appropriate infection treatment, which may lead to an increased risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections associated with chickenpox. If the patient is taking this medicine during an infection, and the symptoms of the infection persist or worsen, they should immediately consult a doctor.
This medicine belongs to a group of medicines (non-steroidal anti-inflammatory drugs) that may adversely affect female fertility. This effect is temporary and reverses after treatment is stopped.
If the patient is having trouble getting pregnant, they should consult their doctor before taking ibuprofen.
The patient should consult their doctor, even if the above warnings refer to past situations.
The medicine is not indicated for children under 12 years of age.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, even those that are available without a prescription.
Do not take Ibuprom RR MAX at the same time as other non-steroidal anti-inflammatory drugs (including COX-2 inhibitors, such as celecoxib or etoricoxib), other painkillers, or acetylsalicylic acid (in analgesic doses). Concomitant use of Ibuprom RR MAX with these medicines increases the risk of side effects.
Ibuprom RR MAX may affect the action of other medicines or other medicines may affect the action of Ibuprom RR MAX, for example:
Also, some other medicines may be affected or may affect treatment with Ibuprom RR MAX. Therefore, before taking Ibuprom RR MAX with other medicines, the patient should always consult their doctor or pharmacist.
3/7
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Do not take Ibuprom RR MAX if the patient is in the last 3 months of pregnancy, as it may harm the unborn child or cause complications during delivery.
Ibuprom RR MAX may cause kidney and heart problems in the unborn child. It may increase the risk of bleeding in the mother and child and cause prolonged or delayed labor. During the first 6 months of pregnancy, Ibuprom RR MAX should not be used unless the doctor considers it absolutely necessary. If treatment is necessary during this period or when trying to conceive, the smallest effective dose should be used for the shortest possible time. From the 20th week of pregnancy, Ibuprom RR MAX, if taken for more than a few days, may cause kidney problems in the unborn child (which may lead to low amniotic fluid levels around the baby) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart.
If treatment is required for a longer period, the doctor may recommend additional monitoring.
Ibuprofen passes into breast milk in very small amounts, and no cases of side effects have been reported in breastfed infants. There is no need to stop breastfeeding when taking ibuprofen for a short period and in small doses.
See the "Warnings and precautions" section.
There is no data on the effect of the medicine on the ability to drive vehicles, operate machinery, and mental performance during treatment with the recommended doses and duration.
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. In case of doubt, consult a doctor or pharmacist.
Adults and adolescents over 12 years of age:for short-term treatment: 1 tablet orally every 4-6 hours.
Use the smallest effective dose for the shortest duration necessary to relieve symptoms. If the symptoms of the infection (such as fever and pain) persist or worsen, consult a doctor immediately (see section 2).
Do not take more than 3 tablets per day.
Elderly patients: no dose adjustment is required.
Do not increase the recommended dose.
If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.
The medicine is intended for short-term use. If symptoms persist, worsen, or new symptoms occur, consult a doctor.
Do not take the medicine for more than 3 days without consulting a doctor.
4/7
If the patient has taken a higher dose of Ibuprom RR MAX than recommended or if a child has accidentally taken the medicine, they should always consult a doctor or go to the nearest hospital to get an opinion on possible health risks and advice on what to do.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain blood), gastrointestinal bleeding (see section 4 below), diarrhea, headache, ringing in the ears, and confusion. It may also cause agitation, drowsiness, disorientation, or coma. Rarely, patients may experience seizures. After taking large doses, drowsiness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness have occurred. Additionally, there may be an extension of prothrombin time/INR, probably due to the disruption of circulating clotting factors. Acute kidney failure and liver damage may occur. In asthmatics, asthma may worsen. Additionally, there may be low blood pressure and difficulty breathing.
There is no specific antidote. The doctor will provide symptomatic and supportive treatment.
Do not take a double dose to make up for a missed dose.
Like all medicines, Ibuprom RR MAX can cause side effects, although not everybody gets them.
If the patient experiences any of the following symptoms, they should stop taking ibuprofen and seek medical help:
Uncommon side effects(affecting 1 to 10 in 1000 patients taking the medicine):
Rare side effects(affecting 1 to 10 in 10,000 patients taking the medicine):
Very rare side effects(affecting less than 1 in 10,000 patients taking the medicine):
5/7
Side effects with unknown frequency(frequency cannot be estimated from available data):
In connection with the use of NSAIDs, reports of edema, hypertension, and heart failure have been made.
Taking medicines like Ibuprom RR MAX may be associated with a slight increase in the risk of heart attack (myocardial infarction) or stroke.
In the case of short-term use of the medicine, side effects are rare.
In elderly patients, there is an increased risk of side effects associated with ibuprofen compared to younger patients. The frequency and severity of side effects can be reduced by using the smallest therapeutic dose for the shortest possible period.
If side effects occur, including any possible side effects not listed in this leaflet, the patient should tell their doctor or pharmacist.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C
By reporting side effects, more information can be collected on the safety of the medicine.
Store the medicine at a temperature below 25°C.
Keep out of sight and reach of children.
Do not use after the expiry date stated on the carton and blister packaging - blister (month/year).
6/7
Labeling on the blister: EXP - expiry date, Lot - batch number.
The active substance of the medicine is ibuprofen in a dose of 400 mg per coated tablet.
The excipients are:
Core tablet:microcrystalline cellulose, maize starch, pregelatinized starch, hydrogenated vegetable oil, crospovidone, talc, colloidal anhydrous silica.
Coating:
polyvinyl alcohol (E 1203), macrogol 3350 (E 1521), titanium dioxide (E 171), talc (E 553b),
aluminum potassium silicate (E 555) and titanium dioxide (E 171) mixture, carnauba wax.
White or almost white, oblong, smooth, biconvex tablets with "RR" embossed on one side.
10 tablets (1 blister of 10),
12 tablets (1 blister of 12),
20 tablets (2 blisters of 10),
24 tablets (2 blisters of 12),
48 tablets (4 blisters of 12),
48 tablets (HDPE bottle),
60 tablets (HDPE bottle).
US Pharmacia Sp. z o.o.
Ziębicka 40
To obtain more detailed information about this medicine, the patient should contact the representative of the marketing authorization holder:
USP Zdrowie Sp. z o.o.
Poleczki 35
Date of last revision of the leaflet:
7/7
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.